Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults

Documenti analoghi

• Pharmacokinetics and Safety of a Fixed‐Dose Combination of Alogliptin and Extended‐Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults
  di: Ji Hye Song, et al.
  Pubblicazione: (2025)
• Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine
  di: Hyung Soon Lim, et al.
  Pubblicazione: (2024)
• Strategic Buried Defect Passivation of Perovskite Emitting Layers by Guanidinium Chloride for High‐Performance Pure Blue Perovskite Light Emitting Diodes
  di: Jung Jae Do, et al.
  Pubblicazione: (2024)
• Enhanced Hole‐Injecting Interface for High‐Performance Deep‐Blue Perovskite Light‐Emitting Diodes Using Dipole‐Controlled Self‐Assembled Monolayers
  di: Hyo Jae Lee, et al.
  Pubblicazione: (2024)
• Pharmacokinetic comparison of subcutaneously administered CT‐P13 (biosimilar of infliximab) via autoinjector and pre‐filled syringe in healthy participants
  di: Ye Chan Park, et al.
  Pubblicazione: (2024)